Recent News

• 06.11.2025 - 46th Annual Goldman Sachs Global Healthcare Conference
• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.02.2025 - Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
• 06.02.2025 - Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
• 05.28.2025 - Martin Fan
• 05.28.2025 - Aclaris Therapeutics to Participate in Two June Healthcare Conferences
• 05.16.2025 - HC Wainwright “HCW@Home” series

Recent Filings

• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - 8-K Current report
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.05.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.05.2025 - 3 Initial statement of beneficial ownership of securities
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.30.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors